Latest Management Changes News

Brickworks Limited shares have been suspended from the ASX following court approval of a scheme of arrangement that will see Washington H. Soul Pattison acquire the company through a subsidiary.

LDR Assets Pty Ltd, controlled by the Lederer Family Office, has made an off-market takeover bid for all stapled securities of the Elanor Commercial Property Fund (ECF) at $0.70 cash per security, offering a premium over recent trading prices and net tangible asset backing. The bid follows concerns about ECF’s declining financial performance and signals potential management changes and delisting.

Metal Bank Limited has agreed to acquire Hastings Technology Metals’ Western Australian gold assets, expanding its portfolio and advancing key projects toward production.

Elanor Investors Group advances its strategic alliance with Rockworth Capital Partners through a $125 million recapitalisation and Firmus acquisition, while rejecting an unsolicited takeover offer for its commercial property fund. The group also reports FY24 results highlighting stabilisation efforts amid high gearing.

Duxton Water Limited has declared its 17th consecutive dividend increase at 3.72 cents per share, fully franked, while removing the discount on its Dividend Reinvestment Plan following a major debt repayment.

Immutep Limited reported a widened loss of A$61.4 million for FY2025, driven by increased R&D and clinical trial expenses, while progressing its lead immunotherapy candidate into a pivotal Phase III lung cancer trial. The company maintains a robust cash position supporting operations through 2026.

Aurora Labs reported a 34% increase in loss after tax to $3.75 million for FY2025, alongside a 327% surge in revenue driven by defence contracts and 3D printing services. The company is progressing its micro gas turbine propulsion systems and pursuing aerospace certification to expand its market footprint.

NeuroScientific Biopharmaceuticals reported a $1.85 million loss for FY25, driven by reduced R&D incentives and increased development costs following its acquisition of StemSmart™ technology. The company is advancing clinical programs, including a Special Access Scheme for Crohn’s disease.

Terragen Holdings reported a $3.72 million loss for FY25, impacted by drought and lower revenues, while launching dry probiotic products targeting feedlots and completing a $4.76 million equity raise.

Eildon Capital Group reported a net loss of $5.7 million for FY2025, weighed down by significant one-off impairments, while pivoting to focused real estate investments with a new $20.8 million joint venture in Queensland.

Platinum Capital Limited reported a 24% drop in net profit for FY2025, underperforming its benchmark, while announcing a strategic withdrawal of a merger scheme and initiating a substantial share buy-back alongside significant board changes.

VGI Partners Global Investments Limited reported a $17.6 million net loss for FY25 but maintained its dividend policy and executed a $73 million share buy-back, signaling confidence amid market challenges.